Chemomab Therapeutics

CMMBNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$13.881 M

$1.93 +7.22%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$8.99M

Loss-making

Shares outstanding

575,381,320

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#417Kala BioKALA$14.5M
#418GT BiopharmaGTBP$14.2M
#419Chemomab TherapeuticsCMMB$13.9M
#420Palatin TechnologiesPTN$13.8M
#421AEON BiopharmaAEON$13.5M

Where these numbers come from

Share counts and financials for Chemomab Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.